EGFR mutation analysis

Alphabetical Test listing

EGFR mutation analysis-12366

  
EGFR mutation analysis
  
12366
  
LAB12366
  
EGFR
  
EGFR
Epidermal growth factor receptor
  

Analysis of the EGFR gene to identify NSCLC patients who may be eligible for TKI therapies. This assay detects mutations in the EGFR gene that confer TKI sensitivity and TKI resistance.

  
Tumor tissue
  

Submit a formalin-fixed, paraffin-embedded (FFPE) tissue block

  

FFPE tissue block

  

Molecular Medicare billing request

Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medical billing request form along with the sample.

  • Complete and submit the form to notify us of the need for Allina Health Laboratory to bill insurance for Molecular testing performed
  • All information requested is required in order for your request to be completed
  

Ambient

  
  • Samples fixed by other means, such as B+, will not be accepted.
  • Decalcified bone specimens will not be accepted as this process degrades DNA.
  • Improper label (unlabeled or mislabeled)
  • Wrong container (anticoagulant or solution)
  • Delay in transport
  • Improper storage
  • Inappropriate timing of collection
  • Interfering substances
  • Slides broken beyond repair
  
AHL - Molecular Diagnostics: D
  
Varies; weekly
  
5 - 7 days
  

Cobas EGFR Mutation Test v2 (IVD, Roche)

  

An interpretive report will be provided

  
81235
  
Yes
  
  
06/26/2013
  
07/27/2018
  
03/13/2020